Verition Fund Management LLC Entera Bio Ltd. Transaction History

Verition Fund Management LLC

  • $16.5 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$4.43 - $6.29 $135,216 - $191,989
-30,523 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$2.92 - $6.5 $89,127 - $198,399
30,523 New
30,523 $183,000

Others Institutions Holding ENTX

# of Institutions
17
Shares Held
5.31M
Call Options Held
0
Put Options Held
0
View Full List

About Entera Bio Ltd.

ENTX Quotes by TradingView
  • Ticker ENTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,809,900
  • Market Cap $57.9M
  • Description
  • Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...
More about ENTX
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email